Congratulations Dr. Robert Welliver and Dr. Tom Oomens on their NIH Grant!
11/13/2019 Congratulations! Read More>>
Image result for Dr. Ashlee Ford Versypt
Dr. Ashlee Ford-Versypt Receives her first NIH Grant of over $1.8 Million
9/03/2019 Congratulations Dr. Ford-Versypt Read More>>
Image result for Dr. mark coggeshall
OCRID's Very Own Dr. Mark Coggshall Receives $12 Million Grant for his Research 
8/20/2019 Congratulations Dr. Coggshall Read More>>
OCRID Director Dr. Lin Liu Elected as a Fellow for the APS 
An effusive congratulation is also in order for our esteemed director, Dr. Lin Liu. He was chosen to be elevated to the status of Fellow for the American Physiological Society! Read More>>
OCRID EAC member, Dr. Adolfo Garcia-Sastre elected as a member of the National Academy of Sciences 
We would like to give a hearty congratulations to our External Advisory Committee member Dr. Adolfo Garcia-Sastre for his election as a member of the National Academy of Sciences.Read More>>
Jordan Metcalf Winner of the OUHSC “Regents award for Superior Research and Creative Activity” 
Dr. Jordan Metcalf has received the Regents Award from the University of Oklahoma Health Sciences center for Superior Research and Creative Activity.Read More>>
OCRID Pilot Project Leader Wins NSF CAREER Award 
OCRID Pilot Project Leader, Ashlee Ford Versypt, assistant professor in Oklahoma State University’s school of chemical engineering, has been awarded the National Science Foundation Faculty Early Career Development (CAREER) Program award, NSF’s most prestigious award in support of early-career faculty. OSU’s chemical engineering school now has five faculty members that have received this award in the past 14 years. Read More>>
Dr. Yu Feng Wins Hall of Fame Competition
OSU Research Wins More>>
Shitao Li, Ph.D. Receives a $1.7 Million Grant
From the National Institutes Health R01 Grant More>>
OCRID Investigators Received Two NIH R01 Grants, Totaling Over $4 million
Dr. Heather Fahlenkamp, Phase I project leader along with Dr. Susan Kovats, OCRID investigator just received a multiple PI NIH R01 grant entitled “A 3D Human Tissue-Engineered Lung Model to Study Immune Responses to Respiratory Syncytial Virus”. This is a 4-year funding with over 2 million and the third R01 that OCRID project leaders received. More>> 
$11.1 million for OSU pioneering respiratory disease research

The *National Institutes of Health (NIH) has awarded $11.1 million to a major biomedical research center at Oklahoma State University to continue the work of more than 60 scientists from three research institutions in the state. OSU’s Oklahoma Center for Respiratory and Infectious Diseases (OCRID) received the grant to fund a second, five-year phase of the center’s research mission begun in 2013 when it was founded. More>>
Two OCRID Teams Won “Swing for the Fences” Grants
Véronique Lacombe and Michael Davis from OSU Department Physiological Sciences and Edward Shaw and Erika Lutter from OSU Department of Microbiology and Molecular Genetics have been awarded "Swing for the Fences" grants. Drs. Lacombe, Lutter and Shaw are OCRID pilot project leaders and Dr. Davis is an OCRID investigator. More.>>
OCRID mentor, Robert C. Welliver Sr. M.D. diagnosed and treated a rare infectious disease
OKLAHOMA CITY - A Blanchard boy is now fully recovered after contracting a rare infectious disease from a tick. It started when Wade White was climbing a tree last fall. More.>>
Image result for Valentin V. Rybenkov
OCRID pilot project leader, Valentin V. Rybenkov, Ph.D. shares $5.7 million grant from NIH for drug-resistant Pseudomonas aeruginosa research 
NORMAN — One of the most dangerous bacteria to humans has a name everyday people will probably find hard to pronounce. Pseudomonas aeruginosa is a special kind of microorganism, University of Oklahoma professor of biochemistry Helen Zgurskaya said. Its entire life has been spent in harsh conditions, and it has devised ways to resist external threats. More.>>
Dr. Gillian Air receives lifetime achievement prize

Dr. Gillian Air, a longtime researcher of the influenza virus and leader at the University of Oklahoma, has been awarded a life time achievement award from the Society for Glycobiology. More>>
Pilot Project Leader, Dr. Ashlee N. Ford Versypt Receives 35 Under 35 Award

The American Institute of Chemical Engineers (AIChE) has selected Dr. Ashlee N. Ford Versypt as one of its 2017 outstanding young professional members under age 35. An assistant professor of chemical engineering at Oklahoma State University, Ford Versypt won the institute’s 35 Under 35 Award in the education category. More>>
Dr. Shanjana Awasthi Receives a Five-Year Award from NIH

Dr. Shanjana Awasthi received a notice of award from NIH for her R01 entitled “Surfactant protein-A regions as TLR4-immunomodulators”. This is a 5-year award totaling $1,826,000. More>>
OCRID Members Receive Seven Grants Totaling $3,700,820

OCRID is pleased to announce that six OCRID pilot project leaders and two OCRID mentors recently received 7 grants totaling $3,700,820. More>>
Dr. Lin Liu’s research is featured in “The Oklahoman”

Working together, scientists from Oklahoma State University, the University of Oklahoma Health Sciences Center and the Oklahoma Medical Research Foundation are advancing adult stem cell research to treat some of today’s most devastating diseases. More>>
Dr's. Shitao Li and Richard Eberle Receive NIH Grants 

Congratulations to OCRID members, Drs. Shitao Li and Richard Eberle, on their recent grant awards from the National institutes of Health! More>>
Dr. Valentin Rybenkov, an OCRID pilot project leader, joins a team of OU researchers to make a discovery

A new class of drugs that combat antibiotic resistance has been discovered by a University of Oklahoma researcher and team. More>>
Collaborations among OCRID Members Enhance Research Funding Opportunities 

One of the missions of OCRID is to promote collaborations among center investigators and thus enhance the ability for OCRID investigators to compete for research funding. More>>
Tom Oomens Receives an Outstanding Score for his NIH Research Proposal 

We would like to congratulate Dr. Tom Oomens on his NIH R21 application receiving an outstanding impact score of 14. More>>
Pilot Project Leader Dr. Wouter Hoff reconstructs the building blocks of the oldest known organism

An Oklahoma State University researcher is one of only a few in the world to reconstruct the building blocks of the oldest known organism. Some are calling his research the possible origin of life. More>>
OCRID new hire, Dr. Shitao Li's research highlighted 

Wednesday, August 3 2016
The flu virus is one of the top ten causes of human deaths according to the Centers for Disease Control and Prevention. At Oklahoma State University’s Center for Veterinary Health Sciences, Shitao Li, Ph.D., is currently conducting biomedical research to develop new antiviral drugs to combat the flu virus. More>>
OCRID Researchers Earn Grants

Four OCRID investigators, Drs. Heather Fahlenkamp, Kenneth Miller, Teleguakula Narasaraju, and Lijun Xia, were recently awarded grants through the Oklahoma Center for the Advancement of Science & Technology (OCAST). More>>
Dr. Anne Pereria Named 2016 National Academy of Inventors Fellow

University of Oklahoma Health Sciences Center Professor Heloise Anne Pereira has been named a 2016 National Academy of Inventors Fellow, a high professional distinction awarded to academic invetors with a prolific spirit of innovation.  More>>
OCRID Investigators honored at the 2015 OSU Convocation

Stillwater - Several OCRID investigators were honored at the 2015 OSU Convocation on December 1, 2015.  Dr. Carey Pope, a member of the Internal Advisory Committee, from Department of Physiological Sciences, CVHS was honored with the 2015 Regents Distinguished Research Award. More>>
OCRID Investigator Inducted into Hall of Fame

Anthony Confer, DVM, MS, PhD, Regents Professor and Walter Sitlington Endowed Chair in Food Animal Research at Oklahoma State University’s Center for Veterinary Health Sciences, was among the 2015 inductees into the Oklahoma Higher Education Hall of Fame. More>>
Meet Dr. Carey Pope
Meet Dr. Carey Pope, PhD, Sitlington Ednowed Chair in Toxicology in the Department of Physiological Sceinces. Pope has spent the past 29 years studying pesticide toxicology ans is known as a world-wide leader in his field. More>>
Two OCRID pilot project leaders receive NIH funding


Oklahoma - The bacteria Chlamydia trachomatis is the leading cause of preventable infection blindness worldwide and is the most frequently reported sexually transmitted bacterial infection.  With help from a National Institute of Health (NIH) grant totaling almost $430,000,  More>>

Dr. Tom Oomen’s research gets attention at the Bio Convention.


Oklahoma - At the BIO Convention, Oklahoma State University’s tech transfer office is pitching several projects from its research scientists for possible commercialization. More>>

Dr. Susan Kovats, an OCRID investigator, discusses the West Nile virus and its correlation with rainfall with the Oklahoman Newspaper

Oklahoma - Dr. Susan Kovats, an OCRID investigator, discusses West Nile virus and its correlation with increased rainfall. Dr. Kovats is funded by NHLBI to study dendritic cell-mediated response during influenza virus infection. More>>
Dr. Robert Welliver, a mentor of COBRE, to speak about influenza at the Kiwanis Club

Edmond - During the May 13th Edmond Kiwanis Club meeting, Dr. Robert Welliver, Chief, Section of Infectious Diseases, Department of Pediatrics at the OU College of Medicine, will discuss his work in researching respiratory and influenza viruses as an OU physician, professor and scientist. More>>
Hildebrand Leads Team in Developing a Personalized Cancer Vaccine
Hilderbrand is leading his team in developing personalized melanoma vaccines that can be tailored to a patients specific needs. Hildebrand's goal is to develop theraputic means to get rid of cancer. More>>
OSU chemical engineer wins Oklahoma BioScience Award

Oklahoma State University researcher Heather Gappa-Fahlenkamp was named winner of the 2015 Researcher Recognition Award this week at the 2015 Oklahoma BioScience Awards dinner at the Embassy Suites Hotel on the Oklahoma Health Center Campus. More>>
OCRID Project Mentor Robert Welliver Works to Develop Vaccine for RSV Infections

Robert Welliver and his research team are working on a vaccine through a grant from the Oklahoma Center for the Advancement of Science and Technology in hopes of reducing infant hospitalization due to respiratory syncytial virus. More>>
OCRID investigator, Dr. Xia finds a new way to treat bacterial and viral infections

Two Oklahoma Medical Research Foundation scientists have made new findings related to blood vessel function and inflammation, key factors in infections as well as a host of conditions from cancer to kidney and autoimmune disease. More>>
OCRID investigator is developing tool for testing, treating lung infections

OSU Chemical Engineering is on the forefront of tissue engineering as researchers such as DR. HEATHER FAHLENKAMP blaze new trails in modeling lung and other human tissue. This research provides hope and opportunities for those with compromised immune systems. More>> 
New Blood Infused

Four faculty members recently joined the Oklahoma Center for Respiratory and Infectious Diseases as a Center Investigator. More>>
Pereira targets Drug-Resistant Bacteria

Anne Pereira discovers and investigates the small protein CAP37 and investigates its ability to kill bacteria. Since her discovery Pereira has founded a company called Biolytx Pharmaceuticals Corp. to take her peptide discoveries to the marketplace. More>>
Congratulations To Dr. Coggeshall For A Remarkable Achievement

A big congratulations to Dr. Mark Coggeshall is in order! He is a mentor of the CoBRE grant. Dr. Coggeshall received a 5 year 14.5M grant from the National Institute of Health to continue their research on Anthrax. More>>
OSU Regents Professor To Lead New Respiratory And Infectious Diseases Center

Lin Liu, Ph.D., has been named director of a new center of excellence at Oklahoma State University’s Center for Veterinary Health Sciences. Liu will lead the Oklahoma Center for Respiratory and Infectious Diseases (OCRID) made possible through a nearly $11.3 million Centers of Biomedical Research Excellence (CoBRE) grant from the National Institutes of Health. More>>
OCRID Investigator Dr. Jerry Malayer Elected as Member of EPSCoR/IDeA Foundation Board of Directors
Oklahoma EPSCoR State Director Jerry Malayer, Ph.D., has been elected a member of the EPSCoR/IDeA Foundation Board of Directors, where he will serve concurrently as secretary and treasurer for the organization.  Officers generally serve a one-year term, according to the Foundation’s website. More>>
Hoff Elected An APS Fellow

Congrats to Dr. Wouter Hoff, one of the recipients of OCRID's pilot project grants , has been elected a Fellow of the American Physical Society.  Dr. Wouter Hoff, professor of microbiology and molecular genetics at Oklahoma State University, has been elected a Fellow of the American Physical Society. More>>
Respiratory Infectious Disease Pilot Projects Launched

The Oklahoma Center for Respiratory and Infectious Diseases recently awarded grants to four pilot projects in the field of respiratory infectious disease research.  The funding comes from a Centers of Biomedical Research Excellence (CoBRE) grant that Oklahoma State University’s Center for Veterinary Health Sciences recently received from the National Institutes of Health. More>>
OCRID To Host 5th Annual Lundberg-Kienlen Lecture

Oklahoma State University’s Center for Veterinary Health Sciences will host the 5th Annual Lundberg-Kienlen Lecture on Wednesday, Nov. 20, at 1:15 p.m. in McElroy Hall Auditorium located at the corner of McFarland and West Farm Road on the OSU Stillwater campus. More>>
National Institutes of Health Awards OSU $11.3 Million Grant to Establish Respiratory Disease Center

A research team headed by Lin Liu, Ph.D., at Oklahoma State University's Center for Veterinary Health Sciences, has received a nearly $11.3 million federal grant to establish the Oklahoma Center for Respiratory and Infectious Diseases. More>>